This page lists all pharmaceutical reports related to the field of Cardiovascular Disorders. The reports include market research reports and pipeline analyses.
Displaying 101 - 150 of 153 results
- What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and Other Vaccine Targets in the 2010-2020 Pipeline
- The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways
- The Future of Orphan Disease Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
- The Future of Metabolic Disorder Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand
- Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs
- Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline
- Stem Cell Research - Market Trends, Investment Trends and Pipeline Analysis
- Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma
- The Future of Blood Disorders Therapeutics, Analysis and Market Forecasts to 2016 - Better and More Cost-Effective Treatment Options Create Opportunities
- Acute Ischemic Stroke - Drug Pipeline Analysis and Market Forecasts to 2015
- Angina Pectoris - Drug Pipeline Analysis and Market Forecasts to 2016
- Regenerative Medicine Markets
- World Pharmaceutical and Biopharmaceutical Market, 2010-2015 (Pipeline Analysis of the Top 50 Companies)
- Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017
- Genetic Testing Global Market Briefing to 2016
- Interventional Cardiology Devices Global Market Briefing to 2016
- US Pharmaceutical Market Outlook 2011-2021
- Cardiovascular Devices Market to 2016 - Cardiac Rhythm Management (CRM) and Interventional Cardiology Devices to be the Key Revenue Generators
- Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions
- Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products
- Cardiac Rhythm Management (CRM) Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
- Future Directions in Regenerative Medicine
- The Future of In Vitro and In Vivo Diagnostic Integration
- Pharmaceutical Key Trends 2011 – Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions
- Pharmaceutical Key Trends 2011 – Pharmaceutical Industry Infrastructure Overview: Pharma innovates, diversifies and contains cost in order to grow profits
- Pharmaceutical Key Trends 2011 – Biosimilar Market Overview: Biosimilar uptake set to accelerate
- Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines
- Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure
- Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development
- Preclinical Models - Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for Targeted Therapies
- Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly
- Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value
- Gleevec (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020
- Adcirca (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020
- Remodulin (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020
- Tyvaso (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020
- Macitentan (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020
- Selexipag (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020
- Riociguat (Pulmonary Arterial Hypertension) - Analysis Forecasts to 2020
- Ventavis (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2017
- Letairis/Volibris (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020
- GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing
- Emerging Countries Cardiovascular Devices Market to 2017 - Increasing Incidence of Cardiovascular Diseases and Lifestyle Disorders to Drive the Market
- Revatio (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020
- Tracleer (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020
- Veletri (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020
- Critical Limb Ischemia (CLI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017